| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 224,7 k € | — | — | — | — | — | ||||||||||||||||||||
| Gross margin | 192,8 k € | -64.4% | 541,4 k € | +92.6% | 281,1 k € | +15.5% | 243,4 k € | -30.7% | 351,1 k € | +49.8% | 234,4 k € | +10.7% | 211,8 k € | +27.3% | 166,3 k € | +11.7% | 149,0 k € | -5.4% | 157,4 k € | +41.0% | 111,6 k € | +6.4% | 104,9 k € | -15.2% | 123,6 k € | +32.3% | 93,5 k € | +12.0% | 83,4 k € | -28.3% | 116,4 k € | +9.9% | 105,9 k € | +6.3% | 99,6 k € | -4.9% | 104,7 k € | +6.1% | 98,7 k € | |
| EBITDA | 155,6 k € | -69.8% | 514,9 k € | +96.8% | 261,7 k € | +9.1% | 239,9 k € | -28.2% | 334,1 k € | +44.9% | 230,6 k € | +9.9% | 209,7 k € | +29.0% | 162,5 k € | +62.7% | 99,9 k € | -27.4% | 137,6 k € | +27.3% | 108,1 k € | +6.2% | 101,8 k € | -15.8% | 120,9 k € | +35.0% | 89,6 k € | +12.7% | 79,5 k € | -30.0% | 113,5 k € | +10.8% | 102,5 k € | +5.8% | 96,9 k € | -4.6% | 101,6 k € | +9.5% | 92,7 k € | |
| Operating profit | 134,4 k € | -72.9% | 495,3 k € | +151.5% | 196,9 k € | +13.7% | 173,1 k € | -35.8% | 269,9 k € | +92.0% | 140,6 k € | +17.5% | 119,7 k € | +35.6% | 88,2 k € | +107.0% | 42,6 k € | -63.3% | 116,2 k € | +50.6% | 77,2 k € | +41.4% | 54,6 k € | +5.3% | 51,9 k € | +361.6% | 11,2 k € | -53.6% | 24,2 k € | -59.0% | 59,1 k € | +37.2% | 43,1 k € | +67.1% | 25,8 k € | -27.0% | 35,3 k € | +76.0% | 20,1 k € | |
| Profit/loss | 114,0 k € | -72.7% | 417,3 k € | +194.3% | 141,8 k € | +14.5% | 123,8 k € | -34.7% | 189,7 k € | +99.6% | 95,1 k € | +7.1% | 88,7 k € | +17.4% | 75,5 k € | +135.8% | 32,0 k € | -55.6% | 72,1 k € | +41.5% | 51,0 k € | +8.9% | 46,8 k € | +29.8% | 36,1 k € | +346.1% | 8,1 k € | -72.7% | 29,6 k € | -19.3% | 36,7 k € | +27.8% | 28,7 k € | +37.0% | 21,0 k € | +5.6% | 19,8 k € | +57.5% | 12,6 k € | |
| Equity | 1,2 M € | +10.3% | 1,1 M € | +40.9% | 782,1 k € | +7.2% | 729,5 k € | +20.4% | 605,6 k € | +18.7% | 510,3 k € | -8.6% | 558,6 k € | +18.9% | 469,9 k € | +19.1% | 394,4 k € | -22.0% | 505,7 k € | +16.6% | 433,6 k € | +13.3% | 382,6 k € | +13.9% | 335,8 k € | +9.1% | 307,7 k € | +2.7% | 299,6 k € | +11.0% | 270,0 k € | +15.7% | 233,3 k € | -22.1% | 299,6 k € | +7.5% | 278,6 k € | +7.7% | 258,8 k € | |
| Total assets | 1,4 M € | +4.9% | 1,3 M € | +22.0% | 1,1 M € | +5.7% | 1,0 M € | -3.1% | 1,1 M € | +2.3% | 1,0 M € | +4.4% | 987,4 k € | +7.4% | 919,7 k € | +67.8% | 548,2 k € | -13.0% | 630,2 k € | +11.4% | 565,6 k € | +4.7% | 540,0 k € | +6.0% | 509,6 k € | +9.6% | 465,0 k € | +24.1% | 374,7 k € | +4.7% | 357,8 k € | +13.2% | 316,0 k € | -14.9% | 371,2 k € | -12.6% | 424,6 k € | -2.3% | 434,7 k € | |
| Cash | 136,6 k € | +8.2% | 126,3 k € | -43.7% | 224,3 k € | +2.4% | 219,1 k € | +17.8% | 186,0 k € | -6.5% | 198,9 k € | +13.2% | 175,7 k € | +81.5% | 96,8 k € | +106.8% | 46,8 k € | -64.3% | 131,0 k € | -19.7% | 163,2 k € | +68.7% | 96,7 k € | +216.8% | 30,5 k € | -50.6% | 61,8 k € | +30.7% | 47,3 k € | -54.9% | 104,9 k € | +791.5% | 11,8 k € | — | 36,4 k € | +142.9% | 15,0 k € | |||
| Debts | 159,7 k € | -25.7% | 215,1 k € | -26.3% | 291,9 k € | +2.2% | 285,6 k € | -35.2% | 441,0 k € | -14.1% | 513,6 k € | +22.0% | 420,9 k € | -4.6% | 441,2 k € | +325.8% | 103,6 k € | -16.8% | 124,5 k € | -5.5% | 131,7 k € | -16.3% | 157,4 k € | -9.4% | 173,8 k € | +10.5% | 157,3 k € | +109.5% | 75,1 k € | -14.5% | 87,9 k € | +6.2% | 82,7 k € | +15.4% | 71,7 k € | -50.9% | 146,0 k € | -17.0% | 176,0 k € | |
Private limited company · Diepenbeek · incorporated on 27/10/1995
Private limited company profitable and well capitalised. Cash position rising (+8.2%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Dokter De Winter Philippe is a Private limited company incorporated in 1995. Its main activity is: General medical practice activities. Its registered office is in Diepenbeek.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette